ArticleClinical and experimental gastroenterology2025
Article in Clinical and experimental gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is an increasing public health concern in Vietnam, particularly among working-age adults (18-60 years). The Methods: A case-control study was conducted with 135 NAFLD patients and 270 age- and sex-matched controls, collected from April to August 2023. Hepatic steatosis was evaluated via ultrasound, and NAFLD was diagnosed in cases without excessive alcohol consumption and other liver conditions. Data on demographics, clinical characteristics, and biochemical markers (eg, lipid profiles, liver enzymes) were collected. The rs738409 variant was genotyped using real-time PCR. Statistical methods included Hardy-Weinberg equilibrium testing, allele and genotype frequency comparisons, multivariable logistic regression adjusting for metabolic covariates, and ROC curve analysis to evaluate the predictive accuracy of rs738409. Results: The frequency of the G allele was significantly higher in NAFLD patients (35.93%) compared to controls (28.15%, Conclusion: The
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.